Recruiting NA Depression

New treatment option for Depression

Official title Neuro-computational Study of Thymic Fluctuations in Mood Disorders

ClinicalTrials.gov ID: NCT07033923

What this study is testing

What it's testing
Depression and bipolar disorder are frequent, debilitating conditions. Both are thought to be primarily caused by an impaired regulation of mood, which is why they are sometimes referred to as "mood disorders".

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older. Healthy volunteers may be eligible.

You may be able to join if

  • Common between groups (DD, BD, control and GP):
  • Having given informed and written consent
  • Being covered by social security For patients with depressive disorder (DD):
  • Having been diagnosed with characterized depressive episode (F32, F33, F34) according to the ICD-10, by a psychiatrist, or having presented this...
  • Presenting a diagnosis of bipolar mood disorder (F31) according to ICD-10, by a psychiatrist

You likely can't join if

  • Common between groups (DD, BD, control and GP):
  • Inability to carry out daily monitoring on mobile application for 12 months
  • legal protection measure (guardianship or curatorship) For control group:
  • Current diagnosis of psychiatric disorder in ICD-10 (F20-F98) or prescription of psychotropic treatment
  • History of depression (F32)
  • Syndrome of dependence on a psychoactive substance other than tobacco
See the full eligibility criteria
Who can join
  • Common between groups (DD, BD, control and GP):
  • Having given informed and written consent
  • Being covered by social security For patients with depressive disorder (DD):
  • Having been diagnosed with characterized depressive episode (F32, F33, F34) according to the ICD-10, by a psychiatrist, or having presented this diagnosis during the past 12 months For patients with bipolar disorder...
  • Presenting a diagnosis of bipolar mood disorder (F31) according to ICD-10, by a psychiatrist
  • Having presented a mood episode (F31.0 - F31.6) diagnosed during the past 12 months by a psychiatrist
What rules you out
  • Common between groups (DD, BD, control and GP):
  • Inability to carry out daily monitoring on mobile application for 12 months
  • legal protection measure (guardianship or curatorship) For control group:
  • Current diagnosis of psychiatric disorder in ICD-10 (F20-F98) or prescription of psychotropic treatment
  • History of depression (F32)
  • Syndrome of dependence on a psychoactive substance other than tobacco
  • Neurological history (in particular history of stroke, coma, epilepsy, neuro- inflammatory, or neuro-degenerative disease)
  • Inability to carry out daily monitoring on mobile application for 12 months For patients and healthy volunteers for whom an MRI (without injection of contrast agent) is proposed
  • Contraindication to MRI: cardiac pacemaker not compatible with MRI, heart valve implant, implant or metallic foreign body
  • Pregnant woman (at the time of MRI)

The study team makes the final eligibility decision.

Where it's taking place

  • Paris, Paris, France
  • Paris, France

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Paris, Paris, France; Paris, France. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.